Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP802962.RAQSlS1ZPevyhcEI787l3wZxDweU62BnsWDuJg-F5hFJk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP802962.RAQSlS1ZPevyhcEI787l3wZxDweU62BnsWDuJg-F5hFJk130_assertion type Assertion NP802962.RAQSlS1ZPevyhcEI787l3wZxDweU62BnsWDuJg-F5hFJk130_head.
- NP802962.RAQSlS1ZPevyhcEI787l3wZxDweU62BnsWDuJg-F5hFJk130_assertion description "[Drug development of MET inhibitors: targeting oncogene addiction and expedience.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802962.RAQSlS1ZPevyhcEI787l3wZxDweU62BnsWDuJg-F5hFJk130_provenance.
- NP802962.RAQSlS1ZPevyhcEI787l3wZxDweU62BnsWDuJg-F5hFJk130_assertion evidence source_evidence_literature NP802962.RAQSlS1ZPevyhcEI787l3wZxDweU62BnsWDuJg-F5hFJk130_provenance.
- NP802962.RAQSlS1ZPevyhcEI787l3wZxDweU62BnsWDuJg-F5hFJk130_assertion SIO_000772 18511928 NP802962.RAQSlS1ZPevyhcEI787l3wZxDweU62BnsWDuJg-F5hFJk130_provenance.
- NP802962.RAQSlS1ZPevyhcEI787l3wZxDweU62BnsWDuJg-F5hFJk130_assertion wasDerivedFrom befree-20150227 NP802962.RAQSlS1ZPevyhcEI787l3wZxDweU62BnsWDuJg-F5hFJk130_provenance.
- NP802962.RAQSlS1ZPevyhcEI787l3wZxDweU62BnsWDuJg-F5hFJk130_assertion wasGeneratedBy ECO_0000203 NP802962.RAQSlS1ZPevyhcEI787l3wZxDweU62BnsWDuJg-F5hFJk130_provenance.